GE Healthcare and MediView XR, a med-tech company that leverages augmented reality, announced their collaboration to co-develop the OmnifyXR Interventional Suite System.
Share: email Subscribe
Weekly Top Stories Tue, 06 Dec 2022
We have 30 articles this week. #ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early #Alzheimer’s Disease. #Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 #LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed #Prostate Cancer. #Lumen Raises $62M for Handheld Device to Measure Metabolic Health. #Solid Biosciences Announces Stockholder Approval of Acquisition of #AavantiBio. #Millstone Medical Outsourcing Completes Acquisition of #Ethide Labs. #Lilly Completes Acquisition of #Akouos Expanding Efforts to Help People with Genetic Diseases
Editor's Choice
1. 
 GE Healthcare Teams up with Augmented Reality Company MediView XR
2. 
 Specialty Pharma’s Next Big Opportunity: It’s Time for Patient Access to Adopt an Open Protocol
3. 
 CTAD 2022: Pivotal Anti-Amyloid Data and New Pathways (Updated)
4. 
 After a Tough Summer, X4 Celebrates Phase III Win in WHIM Syndrome (Updated)
5. 
 Q&A: How Carbon Health Plans to Modernize ‘Disconnected’ Chronic Care
Top 10 M&A Transactions
6. 
 ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Study Met Primary and Key Secondary Endpoints, Showing Statistically Significant Reduction of Clinical Decline in Global Clinical Study of Patients With Early Alzheimer’s Disease
7. 
 Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer
8. 
 LIVTENCITY (maribavir) Receives Positive CADTH Recommendation for Adults with Post-Transplant Cytomegalovirus (CMV) Infection
9. 
 Otsuka and Sunovion Initiate Clinical Development of Ulotaront for the Adjunctive Treatment of Major Depressive Disorder
10. 
 Otsuka Pharmaceutical & Lundbeck Present Positive Data From Multiple Phase 3 Studies Showing Brexpiprazole Significantly Improved Symptoms of Agitation in Patients With Alzheimer’s Dementia
11. 
 Lumen Raises $62M for Handheld Device to Measure Metabolic Health
12. 
 UCLA Spinout PictorLabs Launches with $18.8M to Revolutionize Histopathology
13. 
 TrialSpark announces acquisition of a clinical-stage immunodermatology portfolio and formation of Libertas Bio
14. 
 AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy
15. 
 Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan
Top 4 Venture Funding
16. 
 Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio
17. 
 Surgical Innovation Associates (SIA) Announces Definitive Agreement to be Acquired by Integra LifeSciences
18. 
 Millstone Medical Outsourcing Completes Acquisition of Ethide Labs
19. 
 M&A: NextGen Healthcare to Acquire TSI Healthcare for $68M
Top 4 Partnerships Announcements
20. 
 Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
21. 
 Rocket Pharmaceuticals Completes Acquisition of Renovacor
22. 
 M&A: Carenet Health Acquires Stericycle Communication Solutions
23. 
 Amulet Capital Partners Acquires United Vein & Vascular Centers
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us